Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology

Current status of I-O for the treatment of metastatic colorectal cancer

Date

14 Sep 2020

Session

Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology

Presenters

Sara Lonardi

Authors

S. Lonardi

Author affiliations

Oncology, IRCCS Istituto Oncologico Veneto, 35128 - Padova/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

14 Sep 2020

Welcome and Introduction

Presenter: Markus Möhler

Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology

Resources:

Webcast

14 Sep 2020

I-O for upper GI cancers: Where are we today?

Presenter: Elizabeth Smyth

Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology

Resources:

Webcast

14 Sep 2020

Case study workshop: Expert insights into I-O therapy for GI cancers

Presenter: Elizabeth Smyth

Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology

Resources:

Webcast

14 Sep 2020

Summary and close

Presenter: Markus Möhler

Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology

Resources:

Webcast

14 Sep 2020

Live Q&A - 24 September 2020 - 15:45-16:45

Presenter: Markus Möhler

Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology

Resources:

Webcast